Cannabix
Technologies to Deliver Innovative Breath Logix Alcohol Screening
Device to Texas, USA
Cannabix
is developing alcohol and marijuana breathalyzer devices to give
law enforcement and employers a tool to enhance public
safety
Vancouver, British Columbia, Canada
-- July 29, 2024 -- InvestorsHub NewsWire -- Cannabix Technologies
Inc. (CSE:
BLO) (OTC
PINK: BLOZF) (Frankfurt: 8CT) (the "Company or Cannabix")
developer of alcohol and marijuana breathalyzer screening devices
for law enforcement and the workplace reports that it has commenced
advanced discussions with Smartox of Irving, Texas for potential
sales distribution of the Company's Breath Logix Alcohol screening
device (see Figure 1). The Company has shipped its device
for evaluation, preliminary marketing and business development
purposes.
-
Cannabix is quickly
advancing its Breath Logix
alcohol screening devices with certification, manufacturing,
regulatory and distribution relationships.
-
Smartox is an industry leading
expert in the drug testing field, based in Irving, Texas. Cannabix
is delivering its Breath Logix device for evaluation, preliminary marketing and
business development purposes.
-
The Breath Logix device helps
organizations establish workplace alcohol testing with a fast,
accurate autonomous, alcohol screening process – the device uses
unique pre-calibrated, replaceable, alcohol sensor cartridge, that
saves time and eliminates costly calibrations. The device comes
with its own integration hub for third party access control and
biometric systems. These innovative features have the potential to
significantly advance the reach of alcohol device distributors
worldwide.
Mr. Duffy Nabors, Vice President of
Sales and Marketing for Smartox stated, "We are excited to bring
the Breath Logix to our customers in the United States. Since 2012,
Smartox has successfully introduced several groundbreaking
technologies into the drug and alcohol testing space including
Intelligent Fingerprinting and the SmarTest® Patch. We look forward
to bringing the Breath Logix wall-mounted breath tester to market.
The applications for a device of this type are limitless. The
ability to connect the Breath Logix system to virtually any Access
Control Device and/or biometric identification system makes this a
perfect solution for keeping safety-sensitive environments safe
from the dangers of alcohol consumption in the
workplace."
Figure
1. Breath Logix Alcohol
screening device
Breath Logix Workplace Series
Features
The Breath Logix Workplace Series has a sleek,
compact design with a host of features including patent pending
pre-calibrated cartridge technology which will allow site safety
administrators to easily maintain their devices, and eliminate the
need for costly calibration equipment and time-consuming site
visits from technicians for maintenance. This device can be used for pre-access alcohol
testing, random testing, start-of-shift testing, pre-employment
testing, return-to-work testing and post-incident
testing.
The technology promotes
organizational safety and works to reduce accidents linked to
alcohol consumption.
The Breath Logix Alcohol device automatically
checks the sobriety of a user and can take a picture to confirm and
record identity while a breath sample is being delivered. Upon
detection of positive breath alcohol result, the device will
deliver a precise Blood Alcohol Content (BAC) level on the screen,
and send a real-time alert via text message, e-mail and to a
dedicated web portal. Furthermore, the system logs user BAC for
incident reporting and historical
investigations.
The Breath Logix helps
organizations save money by deploying an autonomous alcohol
screening device which eliminates the need for dedicated alcohol
screening administrators using conventional handheld devices. There
is no assurance that evaluators of the Company's breathalyzer
technology will come to terms on distribution or enter into a sales
agreement with the Company.
About Cannabix Technologies
Inc.
Cannabix Technologies Inc. is a
developer of marijuana and alcohol breathalyzer technologies for
law enforcement, workplaces and laboratories. Cannabix is
developing delta-9 THC and alcohol screening devices. Delta-9 THC
is the primary psychoactive ingredient in cannabis. Breath testing
for delta-9 THC would allow employers and law enforcement
to identify recent marijuana use. Cannabix is the
developer of its Breath Logix Series
of breath alcohol detection devices
for employers and a range of other settings.
We seek Safe
Harbor.
On
behalf of the Board of Directors
"Rav Mlait"
CEO
Cannabix Technologies Inc.
For further information, contact the
Company at
info@cannabixtechnologies.com
The CSE has not
reviewed and does not accept responsibility for the adequacy or
accuracy of this release.
Cautionary Statement
Regarding Forward-Looking Statements
This press release
contains forward-looking information that involves various risks
and uncertainties regarding future events. Such forward-looking
information can include without limitation statements based on
current expectations involving a number of risks and uncertainties
and are not guarantees of future performance of the Company, such
as final development of a commercial or prototype product(s),
successful trial or pilot of company technologies, no assurance
that commercial sales of any kind actually materialize; no
assurance the Company will have sufficient funds to complete
product development. There are numerous risks and uncertainties
that could cause actual results and the Company's plans and
objectives to differ materially from those expressed in the
forward-looking information, including: (i) adverse market
conditions; (ii) risks regarding protection of proprietary
technology; (iii) the ability of the Company to complete
financings; (iv) the ability of the Company to develop and market
its future product; and (v) risks regarding government regulation,
managing and maintaining growth, the effect of adverse publicity,
litigation, competition and other factors which may be identified
from time to time in the Company's public announcements and
filings. There is no assurance that its development of breathalyzer
technology will provide any benefit to the Company, and no
assurance that any proposed new products will be built, will be
successful in beta testing or clinical trials. There is no
assurance that evaluators of the Company's breathalyzer technology
will agree or come to terms on distribution or enter into a sales
agreement, of any kind. There is no assurance that existing "patent
pending" technologies licensed by the Company will receive patent
status by regulatory authorities. The Company is not currently selling
commercial breathalyzers. Actual results and future events could
differ materially from those anticipated in such information. These
and all subsequent written and oral forward-looking information are
based on estimates and opinions of management on the dates they are
made and are expressly qualified in their entirety by this notice.
Except as required by law, the Company does not intend to update
these forward-looking statements.
501-3292 Production Way, Burnaby, B.C.,
V5A 4R4
Phone: (604)
551-7831 Fax:
604-676-2767
info@cannabixtechnologies.com
cannabixtechnologies.com